Get started

Bngobreakout

BNGO Ready to Break? Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25) A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today. Our profit targets will be 3.13 and 3.30 Resistance: 2.50 / 3.00 / 4.00 Support: 2.00 / 1.70 / 1.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:BNGOLong
by Saxo
BNGO Fairly Priced?NASDAQ:BNGO BNGO has seen a steady decline over the last 8 months, you can read my past articles for the reasoning for this. I believe we have now found our fair value of this company. the stock has been steadily holding the $3.00 line for the last one and a half weeks. It has as well been hovering around the oversold (30) on the RSI index. After bears have been manipulating the prices down, it has become clear the mood has shifted. Will we have a Christmas run? I don't believe so, but I believe the new year will be positive prior to the tapering. If you are holding this company for years, the short term price should not matter to you, unless it means you can purchase more! Best of luck all and happy holidays! Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0. 05 , 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGOLong
by braydenboyko
BNGO Gaps, Where Will It Stop?NASDAQ:BNGO Well here we are...In my previous articles I have discussed the long term outlook and the short term outlook of BNGO. For the short term I have been right thus far. I want to talk about a few key factors in the last few days. Many investors have noticed price manipulation in stocks, BNGO included. There is a government investigation going on regarding it. Many investors are calling for the removal of Erik Holmlin. The RSI Indicator suggests that BNGO is oversold coming in at 28.57 today. It has been oversold since November 22, 2021. When looking at the supertrend of EMA50 we can see the huge gap in current price to 50 term average. An even larger gap is found on the 100EMA. For the 50 EMA I suggest we would need to see a 34% increase in share price to confirm a reversal, this is in the short term. This number may come down with a few green days. I believe we need a week of majority green to hold the current range of $3.44 - $4.29 Range. If we see a red week starting Monday I believe we will fall into the $2.57 - $3.44 range. Knowing how fast this stock can fall, we could have some low levels as indicated by the levels above. I worry for the short term price of this stock, will the company be able to sustain such low earnings and exposure? Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGO
by braydenboyko
BNGO Sell Off TodayNASDAQ:BNGO OANDA:US2000USD BNGO down 5.63%...time to panic? Absolutely not, after the rally of small caps over the last two days, it is expected to see a pull back. Short term traders are locking in profits, and volatility was low today (only 5.6Mil). I expect to see the climb of BNGO through the holiday season. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69
NASDAQ:BNGOLong
by braydenboyko
Have We Found The Bottom?? BNGONASDAQ:BNGO Wow...What a tremendous day for BNGO. What's causing this sudden price spike? Are Investors pouring back into the company? Are we seeing a pump? BNGO has been oversold since November 22, 2021, finally it appears that the bleeding is over. Now investors should not get to excited, with the steady decline over the last 8 months, this could just be a green day, and the trend could continue. This could be institutions bull trapping investors. We will know tomorrow if this is the start of a trend reversal. FDA approval could be excellent timing to see an end of the year run, bull sentiment is up 1.28% according to StockTwits. I believe BNGO has faced manipulation, for this reason it has been down in the dumps. As I have always said, everything in finance is fairly priced, and companies stocks will eventually match that fair price. We must understand that the company needs to boost their revenues to sustain long term growth (as mentioned in my previous article), but I believe a time frame of 3-5 years will be bright for the company. With interest rates hiking in 2022, growth stocks may see a decline. This market has many odds stacked against BNGO, but the company has strong financial background, and a revolutionary product. If it can withstand the beatdown, it will fly. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.70 - Most recent addition Average Price: 4.3425
NASDAQ:BNGOLong
by braydenboyko
2
When Will The Bleeding End For BNGO?NASDAQ:BNGO As previously discussed, the long term outlook for BNGO is magnificent. With strong financial management and a revolutionary product, the company is set to break the BioTech industry. So why is the stock doing so poorly in the short term? The company has done very little in sales and has not marketed itself well. It is as simple as that; until the company can find ways to increase earnings, investors will not value them as more than a $2-$3 stock. The company has seen consistent growth in revenue over the last 7 quarters. from 1.14M in Q1 2020 to 4.66M in Q3 of 2021. The growth consistency is something all investors look for in growing companies. I believe we will truly begin to see if BNGO will continue to grow over the next three quarters. It is important to note that small cap stocks have been hit hard by these high inflation periods, as they tend to be growth stocks. If investors do not have the stomach for this market, BNGO is not the play. But investors who are willing to continue to hold, perhaps selling options to generate income, will be rewarded when this company breaks out. The company holds $326 Million in cash, at their current spending rate they must make big plays to increase revenue within the next 8 quarters. It is important to note that BNGO has begun buying smaller BioTech companies, as a result their cash may dwindle far faster than anticipated. This is why I offer the suggestion, that we will know where this company is headed within three to four quarters. My Positions: Today I sold my contracts of: Long Puts - Strike: 4.00 @ 0.22, 12-12-2021, for 0.70 per contract. I completed this in order to avoid the eat away of theta over the coming weeks. I believe in locking in my profits even though I project BNGO to continue to fall well into December. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00
NASDAQ:BNGO
by braydenboyko
1
Finally Some Good News For BNGO??NASDAQ:BNGO Has the down trend of BNGO finally come to an end? I am not one who believes in the reading of charts, I do understand the basis behind it though. The idea that humans exact in a certain way consistently, thus the charts should react in a similar way. I do not believe this is how people should invest, but I do understand the human tendency behind it. So if you want me to confirm your buy signals in this article, it is not the right one for you. I would rather focus on what happened today and why, and what this means for the future. Today BNGO started off the day in a strong downward movement, hitting a low price of $3.73, followed by a close of $4.09. BNGO has been in a free fall in the last few weeks; my previous articles talk about this. I believe the dramatic drop in price today triggered many people, algorithms , and limit buy orders, to buy up this stock. The huge increase in volume today backs this claim; from an average of 9.3M to 12.81M today. As seen on the chart above I have highlighted the candlestick in which I am talking about. What does this mean for the price movement of the stock? TA would suggest this is the end of the downtrend, and I would agree to some extent. To say that one strong day of buys is the end of a down trend is rather reckless thinking, but I would also argue that due to the intensity of the current downtrend, seeing a day of strong buying is a solid indicator that this may be our new floor. As mentioned in previous articles I believe in the sustainability and longevity of this company, and it will be interesting to see how the stock fair over the next couple of weeks. It is important to note that the NASDAQ and the BioTech industry has been down in this same period as BNGO; they are not standalone. If investors morale stays high towards this price it will increase buying power and create momentum in the direction long investors want it to go. That being said dollar cost averaging your way in, if you are a new investor to this company, is the way to go from here, as this stock is highly price elastic. The worst thing for the price of this stock would be a large spike in the upward motion, as it would trigger many people to sell who have held through this rocky road. In order to truly gain momentum in the up trend we will need to see gradual growth, gradual buying, No bad news, and a strong earnings report in March 2022. Current Positions In BNGO: Stock positions @$5.97 Short Call options @1.21 for a strike of $5, for 21-01-2022. Long Put options @0.22 for a strike of $4, for 17-12-2021. This is to hedge against short term downside lost. Long Put Options @0. 05 for a strike of $2, for 21-01-2022. This is my most recent addition to protect against a major free fall in price.
NASDAQ:BNGO
by braydenboyko
BNGO Struggles Continue...What's next? NASDAQ:BNGO As the BNGO struggles continue well into the third week of November 2021, what are the takeaways, and what should investors plan for the future? The Underlying The company is on track to do at least $15 million in revenue over each of the next five years, the EPS will be cut down to the break even point very soon. The company is currently holding $38 million in cash; providing a safety net for their future. With only $25 million in total liabilities, and over $60 million in assets, the company holds a strong framework for profitability. The company currently has $16 million in long term debt; which is small for a biotech industry. BNGO currently has $2.7 million in Net receivables and $2.9 million in accounts payable. The company is in a strong position financially and is managed well by CFO Christopher Stewart. Investors are becoming increasingly bearish towards BNGO, we have seen a week now of strong downturn. What is BNGO's bottom? While predicting a bottom on a stock that is so volatile and price elastic is nearly impossible, We can now see that BNGO has broken is previous support of $4.20. I am confident when I say, the price of BNGO may free fall to pre-pump levels. I am setting my next support target at $2.00. I believe that with the recent pull back of the NASDAQ, BNGO was majorly affected. It will be interesting to see what the price of BNGO will do as the NASDAQ turns back to the upside. Current Positions In BNGO: Stock positions @$5.97 Short Call options @1.21 for a strike of $5, for 21-01-2022. Long Put options @0.22 for a strike of $4, for 17-12-2021. This is to hedge against short term downside lost. Long Put Options @0.05 for a strike of $2, for 21-01-2022. This is my most recent addition to protect against a major free fall in price.
NASDAQ:BNGO
by braydenboyko
What Is Going On With BNGO? NASDAQ:BNGO What in the world is going on with BNGO? It seems as if no matter the news the stock goes down. For a company that is set to record their highest earnings ever, the stock movement does not reflect that. For smaller cap stocks this common, stock pumps, hedging, shorts; all play a role in the price. Why is the stock going down? Earlier this year Wallstreet Bets pumped the stock, it is likely that investors see this as an over valued stock. In the short term they may be right, but investors are failing to understand the potential in this company. The Underlying The company is on track to do at least $15 million in revenue over each of the next five years, the EPS will be cut down to the break even point very soon. The company is currently holding $38 million in cash; providing a safety net for their future. With only $25 million in total liabilities, and over $60 million in assets, the company holds a strong framework for profitability. The company currently has $16 million in long term debt; which is small for a biotech industry, PLTR a major competitor holds close to $200 million in debt. BNGO currently has $2.7 million in Net receivables and $2.9 million in accounts payable. The company is in a strong position financially an is managed well by CFO Christopher Stewart. With the company fundamentally on the path to success, why is it that stock is doing so poorly? Investors clearly believe this stock is overvalued for the current state of the company. I hope to see a bottom of $4.20, but I understand that the company could drop below it's pre-pump under $1 valuation. BNGO dominates the genome mapping industry, and will be the major supplier to governments all around the world. The company has huge upside potential, but may be overvalued in the short term. The negativity amongst investors drives fear into buyers, continuing to push the price lower. As the 25% of institutions gain more confident in the company and increase their positions (Blackrock, Vangaurd, ect...), the stock price will thrive. I am currently holding long on BNGO, and in the mean time generating cash buy selling covered calls. I currently have stock positions @$5.97, and Short Call options @1.21 for a strike of $5, for 21-01-2022. I have now added long put options @0.22 for a strike of $4. This is to hedge against downside lost.
NASDAQ:BNGO
by braydenboyko
BNGO When will the struggles end??BNGO has had its fair share of troubles in the last few months, the stock was pushed during the meme stock pump and dump phase earlier this year. What's next for BNGO? BNGO is by no means a short term hold, the company has been working hard in the industry to provide advancements in OGM (Optical Genome Mapping). Although holding a $1.48B market cap, with a 52 week high of $15.69, BNGO has suffered flat bearish movement in the recent months. With 24.99% of shares held by institutions, this is a strong buy for the long term. I believe that the lack of recent growth comes from the failure to be profitable. With the current year only offering $0.06 in revenue per share, and the operating cashflow being at -$58.41M, it is important to note the company does hold $38.449M in Total cash, the most in companies history. Could they be holding for major research to increase their current assets above $50M? The options Contract market is healthy for this company and stock volatility continues to stay high, It amazes me with an average of 8M shares being traded everyday, that we do not see larger movement in price, this could indicate that moving into the future this will be a stable stock. The true test will be if they will offer dividends to their share holders in the future.
NASDAQ:BNGOLong
by braydenboyko
2
BNGO ready for a breakout?Bionano Genomics, it is in the field of gene sequencing. The company`s product, Saphyr, uses optical genome mapping to help detect structural variations in gene sequencing. Bionano recently acquired BioDiscovery for $100 million, which is a leader in clinical software production. The acquisition may facilitate adoption of the Saphyr system, in $4 billion market segment. I see a strong support at this level and an upside, according to BTIG Research of $10 per share.
NASDAQ:BNGOLong
by TopgOptions
3
BNGO BUY/LONG 4.40 to 19.50 by end 2021 TICKER CODE: BNGO Company Name: Bionano Genomics, Inc. Industry: Healthcare | Biotechnology | USA Position Proposed: BUY Technical Analysis 1. Falling Wedge / Pennant (Forming) 2. Fibonacci Retracement at 0.786 ( Silver Zone) 3. RSI Reached OVERSOLD 4. 1st Take Profit will be at Fibonacci Expansion Safe Take Profit and Flagpole Length Entry: NOW READY (4.40) 1st Partial Take Profit: 19.50 (August-November 2021) 2nd Take Profit: 29.00 (Mid 2022)
NASDAQ:BNGOLong
by traderprosignals